Cannabix Technologies (STU:8CT) Moat Score: 3/10 (As of Jul. 08, 2026)


STU:8CT Cannabix Technologies Inc STU:8CT
32 GF Score
Price €0.34
! 2 Warning Signs
View Full Analysis

What is Cannabix Technologies Moat Score?

Cannabix Technologies STU:8CT +0.58% 32 Moat Score is 3 as of Jul. 08, 2026. GuruFocus rates STU:8CT with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 844 Medical Devices & Instruments companies, Cannabix Technologies ranks better than 75.83% on this metric.

Cannabix Technologies has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Cannabix Technologies has No Moat: Cannabix Technologies Inc has very weak competitive advantages with limited market share and no significant intellectual property or brand strength. The company lacks durable cost advantages, regulatory barriers, and a strong distribution network, resulting in a transient competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Cannabix Technologies might have No Moat - Very weak/transient advantages.

Cannabix Technologies  (STU:8CT) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Cannabix Technologies Moat Score Related Terms

STU:8CT vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Cannabix Technologies's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabix Technologies Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's Moat Score distribution charts can be found below:

* The bar in red indicates where Cannabix Technologies's Moat Score falls into.


STU:8CT
32GF Score
Cannabix Technologies Inc STU:8CT
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Cannabix Technologies (STU:8CT) has a Moat Score of 3 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Cannabix Technologies ranks #204 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 24.2%.
Is Cannabix Technologies' Moat Score too high?
Cannabix Technologies' current Moat Score is 3. Based on the distribution chart, Cannabix Technologies ranks #204 out of 844 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cannabix Technologies has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #204 out of 844 companies for Moat Score. This places Cannabix Technologies in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Cannabix Technologies's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (STU:8CT) has a current Moat Score of 3. The current Moat Score is 3. Cannabix Technologies' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Cannabix Technologies (STU:8CT), the current Moat Score is 3 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabix Technologies Business Description

Other Exchanges BLOZF:USABLO:Canada
Address 3292 Production Way, Suite 501, Burnaby, BC, CAN, V5A 4R4
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
32GF Score

Get the complete analysis for STU:8CT

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price